# ICM Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/icm-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.icm-bio.com
- Total disclosed funding: $23M
- Latest round: Series C (May 31, 2019)
- Investors on record: 8

## About

Based in Seoul, South Korea, and founded in 2012, ICM Co., Ltd. operates as a biopharmaceutical firm that develops and manufactures gene therapeutic vectors for the treatment of degenerative diseases in patients. In May 2021, ICM Co., Ltd. raised KRW 21 billion in pre-IPO funding from new investors DS Asset Management, Hana Capital, and Welcome Asset Management, with participation from returning investors Atinum Investment, IMM Investment, LB Investment, and Stonebridge Ventures. As of August 2023, the company is led by its CEO Dae-Won Kim. ICM Co., Ltd. specializes in the creation of gene therapy products manufactured using the OASys production technique. The company has developed Adeno-Associated Virus (AAV), a non-pathogenic virus composed of a capsid with a diameter of 18-25nm and a icosahedral shape, encapsulating a single-stranded DNA of 4.7-6kb in length. The company will use the May 2021 funding to develop innovative new drugs for degenerative diseases and prepare for listing on the KOSDAQ market.

## Funding rounds

- Series C, May 31, 2019, $17M — LB Investment, Atinum Investment, IMM Investment, Time Folio Asset Management, BSK Investment, Stonebridge Ventures, Yuanta Securities Korea
- Series B, Jun 28, 2017, $5.2M — Atinum Investment, IMM Investment, Stonebridge Ventures
- Seed, Sep 18, 2012, $0.4M — Yonsei Technology Holdings

## Investors

- Yonsei Technology Holdings (https://capitalatlas.ai/funds/yonsei-technology-holdings) — Seed
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series B, Series C
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B, Series C
- Stonebridge Ventures — Series B, Series C
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series C
- Time Folio Asset Management — Series C
- BSK Investment (https://capitalatlas.ai/funds/bsk-investment) — Series C
- Yuanta Securities Korea (https://capitalatlas.ai/funds/yuanta-securities-korea) — Series C